M. Azzi, C. Betancur, I. Sillaber, R. Spanagel, W. Rostène et al., Repeated Administration of the Neurotensin Receptor Antagonist SR 48692 Differentially Regulates Mesocortical and Mesolimbic Dopaminergic Systems, Journal of Neurochemistry, vol.71, issue.3
DOI : 10.1046/j.1471-4159.1998.71031158.x

M. Baumann and R. Rothman, Effects of acute and chronic cocaine on the activity of tuberoinfundibular dopamine neurons in the rat, Brain Research, vol.608, issue.1, pp.175-179, 1993.
DOI : 10.1016/0006-8993(93)90792-L

C. Betancur, W. Rostène, and A. Bérod, Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum, Molecular Brain Research, vol.44, issue.2, pp.334-340, 1997.
DOI : 10.1016/S0169-328X(96)00289-6
URL : https://hal.archives-ouvertes.fr/inserm-00276420

C. Blaha, A. Coury, H. Fibiger, and A. Phillips, Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: Cross-validation using in vivo voltammetry and microdialysis, Neuroscience, vol.34, issue.3, pp.699-705, 1990.
DOI : 10.1016/0306-4522(90)90176-5

F. Bordi and E. Meller, Enhanced behavioral stereotypies elicited by intrastriatal injection of D1 and D2 dopamine agonists in intact rats, Brain Research, vol.504, issue.2, pp.276-283, 1989.
DOI : 10.1016/0006-8993(89)91368-1

B. Borowsky and C. Kuhn, Monoamine mediation of cocaine-induced hypothalamo? pituitary-adrenal activation, J Pharmacol Exp Ther, vol.256, pp.204-210, 1991.

B. Borowsky and C. Kuhn, Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses, Brain Research, vol.543, issue.2, pp.301-306, 1991.
DOI : 10.1016/0006-8993(91)90041-S

P. Brun, R. Steinberg, L. Fur, G. Soubrié, and P. , Blockade of Neurotensin Receptor by SR 48692 Potentiates the Facilitatory Effect of Haloperidol on the Evoked In Vivo Dopamine Release in the Rat Nucleus Accumbens, Journal of Neurochemistry, vol.64, issue.5, pp.2073-2079, 1995.
DOI : 10.1046/j.1471-4159.1995.64052073.x

M. Cador, A. Kelley, L. Moal, M. Stinus, and L. , Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat, Psychopharmacology, vol.206, issue.2, pp.187-196, 1985.
DOI : 10.1007/BF00428412

P. Piazza, M. Barrot, F. Rougé-pont, M. Marinelli, S. Maccari et al., Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission, Proceedings of the National Academy of Sciences, vol.93, issue.26, pp.15445-15450, 1996.
DOI : 10.1073/pnas.93.26.15445

N. Pilotte, W. Mitchell, L. Sharpe, D. Souza, E. Dax et al., Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain, Synapse, vol.206, issue.2, pp.111-120, 1991.
DOI : 10.1002/syn.890090205

M. Poncelet, J. Souilhac, C. Gueudet, J. Terranova, D. Gully et al., Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats, Psychopharmacology, vol.105, issue.2, pp.237-241, 1994.
DOI : 10.1007/BF02245067

R. Rivest, F. Jolicoeur, and C. Marsden, Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo, Neuropharmacology, vol.30, issue.1, pp.25-33, 1991.
DOI : 10.1016/0028-3908(91)90038-D

C. Rivier and W. Vale, Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism, Brain Research, vol.422, issue.2, pp.403-406, 1987.
DOI : 10.1016/0006-8993(87)90953-X

P. Robledo, R. Maldonado, and G. Koob, Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat, Brain Research, vol.622, issue.1-2, pp.105-112, 1993.
DOI : 10.1016/0006-8993(93)90808-Z

W. Rowe, A. Nicot, S. Sharma, D. Gully, C. Walker et al., Central Administration of the Neurotensin Receptor Antagonist, SR48692, Modulates Diurnal and Stress-Related Hypothalamic-Pituitary-Adrenal Activity, Neuroendocrinology, vol.66, issue.2, pp.75-85, 1997.
DOI : 10.1159/000127223

V. Santucci, C. Gueudet, R. Steinberg, L. Fur, G. Soubrié et al., Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: Evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade, Synapse, vol.221, issue.4, pp.370-380, 1997.
DOI : 10.1002/(SICI)1098-2396(199708)26:4<370::AID-SYN5>3.0.CO;2-3

R. Steinberg, P. Brun, M. Fournier, J. Souilhac, D. Rodier et al., SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission, Neuroscience, vol.59, issue.4, pp.921-929, 1994.
DOI : 10.1016/0306-4522(94)90295-X

E. Szigethy and A. Beaudet, Correspondence between high affinity125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: A combined radioautographic and immunohistochemical light microscopic study, The Journal of Comparative Neurology, vol.150, issue.1, pp.128-137, 1989.
DOI : 10.1002/cne.902790111

S. Tanganelli, O. Connor, W. Ferraro, L. Bianchi, C. Beani et al., Facilitation of gaba release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens, Neuroscience, vol.60, issue.3, pp.649-657, 1994.
DOI : 10.1016/0306-4522(94)90493-6

J. Wagstaff, L. Bush, J. Gibb, and G. Hanson, Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity, Brain Research, vol.665, issue.2, pp.237-244, 1994.
DOI : 10.1016/0006-8993(94)91343-9